The annual European MedTech Forum has always been a forward-thinking event, both in terms of its production values, which have soared since its humble beginnings, and the topics it chooses to address. This year’s event promises to be no exception. If anything, the conversation will be even livelier than usual, as speakers and attendees will have had ample time to parse the vote of the European Commission’s ENVI committee on the new medical device regulations, scheduled for 18 September.
Moving from the bustle of Brussel’s city centre to the more verdant climes of Dolce La Hulpe just outside of town, the event is organised under the theme, New Rules, New Markets: Medical Devices and Diagnostics’ Place in a Changing Europe. Highlights include:
- European Commissioner for Consumer Protection Neven Mimica, who will speak during a session devoted to the future of industry from a medtech value perspective on 11 October. Mimica is responsible for the medical products sector and has said that he wants to maintain industry’s competitive edge.
- In what has become an annual event, Ernst & Young will present its latest findings on the trends and prospects for the global medical technology industry on 10 October.
- Always provocative and insightful, the CEO Roundtable Debate returns on 10 October. This year’s participants are Vivian Wang, President of Lifescan EMEA, Johnson & Johnson; Rob ten Hoedt, Senior Vice President and President EMEA and Canada, Medtronic; and Katarzyna Mazur, President EMEA, Zimmer.
- A report on the way forward for the medtech industry, and the new business models that will guide it, will be presented to attendees at the event. The report was prepared jointly by Boston Consulting Group and MedTech Europe.
The European MedTech Forum kicks off with a reception and walking dinner the evening of 9 October and runs through the morning of 11 October. For more information and to register to attend, go to www.medtechforum.eu.
That was then—read some of our coverage of last year’s MedTech Forum: